Pharma, comms and patient group leaders join judging panel for Patient Partnership Index 2021
11th March 2021
Senior leaders from UK and European pharma have come together to judge the Patient Partnership Index 2021. Now in its second year, the Index provides companies in the pharmaceutical and biotech industry the opportunity to showcase partnerships with patient organisations in communications and advocacy over the past year, including those in response to the COVID-19 pandemic.
This year, the Index has opened to above country campaigns, allowing projects from around the world to celebrate their impact and share their insights. Entries are awarded GOLD, SILVER and FINALIST standards by the judging panel, against a metric developed by healthcare specialist communications agency and co-creators of the Index, OVID Health.
The Patient Partnership Index 2021 provides a unique opportunity for UK and global pharmaceutical companies to showcase, benchmark and measure the quality and impact of their advocacy with patient groups - News - PharmaTimes